Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
162 Leser
Artikel bewerten:
(0)

EcoPhage and Maian have entered into a distribution agreement for Brazil

Maian will distribute and market GoldenEco, EcoPhage's innovative solution to control bacterial diseases in Tomatoes and Pepper, to the Brazilian market.

OR YEHUDA, Israel, Nov. 20, 2024 /PRNewswire/ -- EcoPhage, a pioneer in the development and commercialization of bacteriophages-based bactericides with minimal environmental impact and maximum efficacy, has signed a distribution agreement with Maian Ltda, to market its GoldenEco in the Brazilian market.

GoldenEco was developed by EcoPhage, to control bacterial diseases in tomatoes and peppers with a clear vision to reduce the usage of Copper and Antibiotics and positioned it as a safe, natural and residue-free solution to control bacterial diseases in agriculture.

The proven platform of EcoPhage screens, maps and characterizes bacteriophages to design a cocktail to control bacterial diseases and was developed together with the Weizmann institute of Science.

Maian is a global company specializing in the import, distribution, manufacturing, and development of raw materials for the food, cosmetics, pharmaceutical, agricultural, and other industries. The company boasts the largest portfolio of 100% natural and sustainable substitutes, free from petroleum derivatives and animal origin, among others, and is headquartered in Brazil. Brazil is ranked 6th globally in the production of tomatoes with nearly 20 million tones harvested each year and more than 60,000 hectares of tomatoes and peppers.

"Copper and Antibiotic are suffering from increasing resistance level and higher regulatory pressure", said Guy Elitzur, EcoPhage's CEO, "and we bring exactly the solution for this. GoldenEco is based on our innovative bacteriophages platform and shows superior performance in the field with added values of better quality and higher yield. We have high expectations from this engagement with a great partner like Maian to bring GoldenEco into the important Brazilian market".

"It is an important milestone for us", says Angel Dachs, the CEO of Maian Ltda., "GoldenEco is being added to our portfolio for vegetables and strengthen our innovative approach and put is in a complete differentiation point in the market and we are very happy with it".

About Maian Ltda :

Maian is a global company specializing in the import, distribution, manufacturing, and development of raw materials for the food, cosmetics, pharmaceutical, agricultural, and other industries. The company boasts the largest portfolio of 100% natural and sustainable substitutes, free from petroleum derivatives and animal origin, among others, and is headquartered in Brazil.

About Us:

Ecophage pioneers the development and commercialization of bacteriophages-based bactericides with minimal environmental impact and maximum efficacy, addressing a crucial issue in global agriculture. Our innovative products harness the power of bacteriophages-viruses uniquely targeting bacteria-to prevent and cure plants, offering nontoxic solutions for bacterial diseases.

Our vision is clear - transformation of the global bactericides market in agriculture into more sustainable and safer to human, living and the environment.

We are doing that by setting up the mission of revolutionizing agriculture by increasing plant yield, reducing disease-related losses, and promoting sustainability. The foundation of our success lies in a proprietary technological platform co-developed with the prestigious Weizmann Institute of Science. Unlike conventional pesticides that often cause environmental harm and exhibit low efficacy, our bactericides represent a natural solution with minimal negative impact, high specificity, and superior effectiveness.

Contact information: info@ecophage.com

Cision View original content:https://www.prnewswire.co.uk/news-releases/ecophage-and-maian-have-entered-into-a-distribution-agreement-for-brazil-302311562.html

© 2024 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.